rhabdomyosarcoma Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (2)
Phase 2 (1)

Interventional (3)

National Cancer Institute (NCI) (2)
Seattle Children's Hospital (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (3)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadneuroblastoma

I am/have/hadmyelosuppressive chemotherapy

I am/have/hadneutrophil count

I am/have/hadbone marrow infiltration

I am/have/hadgraft versus host disease

I am/have/hadmetastasis

I am/have/hadbiological therapy

I am/have/hadplatelet count

I am/have/hadpleural effusions

I am/have/hadrecurrent disease

I am/have/hadmedulloblastoma

I am/have/hadsolid tumor

I am/have/hadcns tumor

I am/have/hadstem cell infusion

I am/have/hadantibody therapy

I am/have/hadplatelet transfusion

I am/have/hadx-rays

I am/have/hadlymphoma

added new label for I am/have/had

I am looking for

I am looking forpediatric

I am looking formetaiodobenzylguanidine

I am looking foriobenguane

I am looking fornitrosourea

I am looking forgrowth factor

I am looking forpegfilgrastim

I am looking forantineoplastic

I am looking forhematopoietic growth factors

I am looking foranticonvulsants

I am looking fortumor markers

I am looking forinterleukins

I am looking fortrastuzumab

I am looking forcytokines

I am looking formelanoma

I am looking forcorticosteroid therapy

I am looking forinterferon

I am looking foranticancer agents

I am looking forcetuximab

I am looking forcorticosteroids

I am looking forradiopharmaceutical

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Dermatology
Recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

This is a phase I, open-label, non-randomized study that will enroll pediatric and young adult research participants with relapsed or refractory non-CNS solid tumors to evaluate the safety, feasibility, and efficacy of administering T cell products derived from the research participant's blood that have been genetically modified to express a …

i131 mibg therapy

biologic therapy

biological therapy

iobenguane

tumors in children

0 views
19 Feb, 2024

Phase 2
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

radiopharmaceutical therapy

autologous stem cell infusion

seizure disorder

nitrosourea

cancer therapy

0 views
19 Feb, 2024

Phase 1
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Background Metastasis is the spread of cancer from one organ to a nonadjacent organ. It causes 90% of cancer deaths. No treatment specifically prevents or reduces metastasis. Researchers hope a new drug can help. It stops cancer cells from growing and spreading further and possibly shrink cancer lesions in distant …

primary tumor

MRI

ct scan

pancreatic cancer

inherited long qt syndrome

0 views
19 Feb, 2024